AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Cancer Innovation Article
PDF (383.9 KB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Commentary | Open Access

Not Whether, but in Whom: Reframing Antibody–Drug Conjugate Sequencing in Metastatic Breast Cancer

Comprehensive Cancer Center, UOC Medical Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, Rome, Italy
Show Author Information

Graphical Abstract

References

【1】
【1】
 
 
Crossref Google Scholar
Cancer Innovation
Volume 5 Issue 5,
November 2026
Article number: e70085
DOI: 10.1002/cai2.70085

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Cite this Report
Close
Close
Cite this article:
Orlandi A. Not Whether, but in Whom: Reframing Antibody–Drug Conjugate Sequencing in Metastatic Breast Cancer. Cancer Innovation, 2026, 5(5): e70085. https://doi.org/10.1002/cai2.70085

6

Views

0

Downloads

0

Crossref

0

Web of Science

0

Scopus
Received: 04 August 2026
Revised: 24 August 2026
Accepted: 03 September 2026
Published: 10 October 2026
© 2026 The Author(s). Tsinghua University Press.

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.